argenx SE (ARGX) NASDAQ
$552.56 10.56 (1.95%)
Market Cap: $33.04B
As of 09/09/24 04:00 PM EDT. Market closed.
argenx SE (ARGX)
NASDAQ
$552.56
10.56 (1.95%)
Market Cap: $33.04B
As of 09/09/24 04:00 PM EDT. Market closed.
Add to Portfolio
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, and chronic inflammatory demyelinating ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Full Time Employees
1,148
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Full Time Employees
1,148
URL
Address
Willemstraat 5, Breda, 4811 AH.
PRICE CHART FOR ARGENX SE
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$547.59
Previous Close
$542
Days Range
$544.44 - $554.74
52 week range
$327.73 - $554.74
Volume
311,268
Avg. Volume (30 days)
356,901
Market Cap
$33.04B
Dividend Yield
-
P/E
(156.98)
Shares Outstanding
59,796,300
Open
$547.59
Previous Close
$542
Days Range
$544.44 - $554.74
52 week range
$327.73 - $554.74
Volume
311,268
Avg. Volume (30 days)
356,901
Market Cap
$33.04B
Dividend Yield
-
P/E
(156.98)
Shares Outstanding
59,796,300
FINANCIAL STATEMENTS FOR ARGENX SE
LOADING...
Open in: 
Open in:
FUNDS WITH A POSITION IN ARGENX SE
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| CAPITAL WORLD INVESTORS | 1,511,494 | 0.11% | -18.94% | Growth At A Reasonable Price |
| BLACKROCK INC. | 1,011,291 | 0.00984% | -3.44% | Other |
| HOLOCENE ADVISORS, LP | 425,614 | 0.76% | -12.93% | Growth At A Reasonable Price |
| BAMCO INC /NY/ | 261,478 | 0.32% | -1.95% | Growth At A Reasonable Price |
| ORBIMED ADVISORS LLC | 209,100 | 1.78% | 37.93% | Other |
| BAKER BROS. ADVISORS LP | 111,904 | 0.61% | -26% | Other |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 121,900 | 1.78% | Exited | Growth At A Reasonable Price |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 106,507 | 0.08% | New | Other |
| D. E. SHAW & CO., INC. | 43,882 | 0.02% | -57.45% | Other |
| BALYASNY ASSET MANAGEMENT L.P. | 45,164 | 0.03% | -20.83% | Event Driven |
| CANDRIAM S.C.A. | 51,418 | 0.13% | 34.77% | Other |
| MELQART ASSET MANAGEMENT (UK) LTD | 38,000 (Call) | 1.35% | New | Event Driven |
| D. E. SHAW & CO., INC. | 32,900 (Put) | 0.01% | No change | Other |
| SOROS FUND MANAGEMENT LLC | 30,000 | 0.2% | Exited | Other |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 28,309 | 0.12% | 69.85% | Growth |
| GEODE CAPITAL MANAGEMENT, LLC | 27,152 | 0.00102% | 3.52% | Other |
| D. E. SHAW & CO., INC. | 7,100 (Call) | 0.00286% | No change | Other |
| RENAISSANCE TECHNOLOGIES LLC | 1,200 | 0.00074% | Exited | Other |
| TUDOR INVESTMENT CORP ET AL | 550 | 0.00121% | New | Event Driven, Other |
CHANGE IN SHARES OUTSTANDING FOR ARGENX SE
STOCK BUYBACKS FOR ARGENX SE
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 06/30/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
3.90%
2Q
06/30/2023
6.66%
4Q
12/31/2022
9.23%
6Q
06/30/2022
11.13%
8Q
12/31/2021
16.30%
10Q
06/30/2021
17.30%
12Q
12/31/2020
30.81%
14Q
06/30/2020
36.63%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ARGENX SE
LOADING...